Skip to main content
Equibles

Graham Capital Management, L.P.

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1315421 ROWAYTON, CT
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$236,845
-$108,364 QoQ
Shares Held
207,759
-16.3% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#52
of 170 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $4,664,055 across 12 Drug Manufacturers - Specialty & Generic names. AKBA ranks #9 (5.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TAK
Takeda Pharmaceutical Co Ltd
 75,653 $1,212,717
2 HLN
Haleon plc
 55,057 $513,681
3 BHC
Bausch Health Companies Inc.
 101,971 $502,717
4 AMRX
Amneal Pharmaceuticals, Inc.
 24,035 $416,045
5 PBH
Prestige Consumer Healthcare Inc.
 7,136 $337,318
6 COLL
Collegium Pharmaceutical, Inc
 8,555 $309,691
7 ZTS
Zoetis Inc.
 4,304 $309,285
8 PRGO
PERRIGO Co plc
 28,290 $293,933

All Filings in AKBA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $236,845 207,759
2026-03-31 $345,209 248,352
2025-12-31 $606,268 376,564
2025-09-30 $627,834 229,976
2025-06-30 $138,898 38,159
2025-03-31 $33,701 17,553
2024-06-30 $58,776 57,624
2024-03-31 $52,678 28,786
2023-12-31 $29,304 23,633
2023-06-30 $24,326 26,586